VIKING GLOBAL PERFORMANCE LLC

See Explanation of Responses at IMCLONE SYSTEMS INC · on record since May 16, 2006
Director at IMCLONE SYSTEMS INC · on record since May 8, 2006
10% owner at AXON ENTERPRISE, INC. · on record since Jul 13, 2016
10% owner at APi Group Corp · on record since Mar 7, 2024
10% owner at Arbutus Biopharma Corp · on record since Jul 13, 2016
10% owner at Myovant Sciences Ltd. · on record since Oct 26, 2016
10% owner at Wayfair Inc. · on record since Oct 8, 2014
10% owner at FIRST DATA CORP · on record since Oct 15, 2015
Former 10% Owner at Editas Medicine, Inc. · on record since Feb 9, 2016
10% owner at Editas Medicine, Inc. · on record since Feb 8, 2016
10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
10% owner at BridgeBio Pharma, Inc. · on record since Jun 28, 2019
Former 10% Owner at Arbutus Biopharma Corp · on record since Jul 12, 2019
Former 10% Owner at AXON ENTERPRISE, INC. · on record since Jul 12, 2019
Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
Former 10% Owner at Myovant Sciences Ltd. · on record since Jul 12, 2019
10% owner at Roivant Sciences Ltd. · on record since Oct 1, 2021
10% owner at ADVANCED PHOTONIX INC · on record since Jan 5, 2022
10% owner at · on record since Jun 26, 2019

Insider trading activity of VIKING GLOBAL PERFORMANCE LLC

Transactions on record: 14; since May 5, 2006

Open-market buys: 3; $166K

Open-market sells: 3; $226.8M

Companies traded: 5; last filing Mar 7, 2024

Figures computed from official regulatory filings — .

Companies where VIKING GLOBAL PERFORMANCE LLC has traded

2 tx · $104.1M · Mar 7, 2024
1 tx · $122.7M · Jan 30, 2020
3 tx · $166K · Jun 6, 2019
1 tx · $50M · Oct 17, 2017
7 tx · May 5, 2006

Track record of VIKING GLOBAL PERFORMANCE LLC

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of VIKING GLOBAL PERFORMANCE LLC

Co-insiders of VIKING GLOBAL PERFORMANCE LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
APi Group CorpListing on record	Mar 7, 2024	Sell	-2,977,845	34.25 USD	$102M		SEC
APi Group CorpListing on record	Mar 7, 2024	Sell	-60,772	34.25 USD	$2.1M		SEC
Adaptive Biotechnologies CorpListing on record	Jan 30, 2020	Sell	-4,912,899	24.98 USD	$122.7M		SEC
Urovant Sciences Ltd.Listing unverified	Jun 6, 2019	Buy	7,500	7.59 USD	$56.9K	conv 47ClusterFirst in 12mo	SEC
Urovant Sciences Ltd.Listing unverified	Jun 6, 2019	Buy	6,540	8.02 USD	$52.5K	conv 30Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Jun 6, 2019	Buy	7,082	8.00 USD	$56.7K	conv 23Cluster	SEC
Arbutus Biopharma CorpListing on record	Oct 17, 2017	BuyD (derivative)	500,000	100.00 USD	$50M	ClusterFirst in 12mo	SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-3,315	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
APi Group CorpListing on record	Mar 7, 2024	Sell	-2,977,845	34.25 USD	$102M		SEC
APi Group CorpListing on record	Mar 7, 2024	Sell	-60,772	34.25 USD	$2.1M		SEC
Adaptive Biotechnologies CorpListing on record	Jan 30, 2020	Sell	-4,912,899	24.98 USD	$122.7M		SEC
Urovant Sciences Ltd.Listing unverified	Jun 6, 2019	Buy	7,500	7.59 USD	$56.9K	conv 47ClusterFirst in 12mo	SEC
Urovant Sciences Ltd.Listing unverified	Jun 6, 2019	Buy	6,540	8.02 USD	$52.5K	conv 30Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Jun 6, 2019	Buy	7,082	8.00 USD	$56.7K	conv 23Cluster	SEC
Arbutus Biopharma CorpListing on record	Oct 17, 2017	BuyD (derivative)	500,000	100.00 USD	$50M	ClusterFirst in 12mo	SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-5,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
IMCLONE SYSTEMS INCListing unverified	May 5, 2006	AwardD (derivative)	-3,315	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC